Qing Song Health Co.,Ltd. (TPE:6931)
Taiwan · Delayed Price · Currency is TWD 35.55
0.00 (0.00%)
Nov 13, 2026, 1:30 PM CST
Qing Song Health Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,263 | 1,122 | 982.56 | 868.66 | 636.69 | 357.54 | |
Revenue Growth | 16.75% | 14.16% | 13.11% | 36.44% | 78.08% | 48.83% |
Cost of Revenue | 1,069 | 974.07 | 858.74 | 753.65 | 571.12 | 330.73 |
Gross Profit | 193.37 | 147.62 | 123.82 | 115.02 | 65.57 | 26.81 |
Selling, General & Admin | 102.54 | 89.62 | 79.7 | 61.11 | 51.66 | 31.54 |
Other Operating Expenses | -1.92 | -0.21 | 0.01 | 0.08 | -0.41 | -0.72 |
Operating Expenses | 100.65 | 90.59 | 79.75 | 61.5 | 51.25 | 30.79 |
Operating Income | 92.72 | 57.03 | 44.07 | 53.52 | 14.32 | -3.98 |
Interest Expense | -27.87 | -25.27 | -23.01 | -17.64 | -14 | -11.3 |
Interest & Investment Income | 12.02 | 10.4 | 4.88 | 3.16 | 0.8 | 0.59 |
Earnings From Equity Investments | - | - | - | - | - | -0.16 |
Currency Exchange Gain (Loss) | 7.11 | 7.11 | - | - | - | - |
Other Non Operating Income (Expenses) | 163.66 | 27.38 | 25.81 | 37.37 | 26.5 | 12.99 |
EBT Excluding Unusual Items | 247.64 | 76.65 | 51.75 | 76.42 | 27.61 | -1.87 |
Gain (Loss) on Sale of Investments | 36.31 | 36.31 | -0.48 | 3.69 | -1.05 | 0.04 |
Gain (Loss) on Sale of Assets | -1.01 | -1.01 | -0.61 | -0.97 | -0.29 | 0.01 |
Other Unusual Items | - | - | - | - | 1.22 | 1.46 |
Pretax Income | 282.95 | 111.96 | 50.66 | 79.14 | 27.5 | -0.36 |
Income Tax Expense | 26.93 | 18.28 | 9.96 | 20.31 | 8.98 | -0.58 |
Earnings From Continuing Operations | 256.02 | 93.67 | 40.7 | 58.83 | 18.52 | 0.22 |
Minority Interest in Earnings | -10.71 | -1.97 | -0.15 | 0.57 | 4.81 | -2.18 |
Net Income | 245.31 | 91.7 | 40.55 | 59.4 | 23.33 | -1.97 |
Net Income to Common | 245.31 | 91.7 | 40.55 | 59.4 | 23.33 | -1.97 |
Net Income Growth | 275.70% | 126.14% | -31.73% | 154.61% | - | - |
Shares Outstanding (Basic) | 66 | 66 | 60 | 60 | 60 | 60 |
Shares Outstanding (Diluted) | 67 | 66 | 60 | 60 | 60 | 60 |
Shares Change | 3.48% | 9.86% | -0.01% | 0.01% | 0.01% | 15.91% |
EPS (Basic) | 3.69 | 1.39 | 0.68 | 0.99 | 0.39 | -0.03 |
EPS (Diluted) | 3.68 | 1.39 | 0.68 | 0.99 | 0.39 | -0.04 |
EPS Growth | 262.99% | 105.84% | -31.73% | 156.24% | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -308.41 | -152.12 | 123.14 | -22.26 | 34.85 | 13.83 |
Free Cash Flow Per Share | -4.63 | -2.31 | 2.05 | -0.37 | 0.58 | 0.23 |
Dividend Per Share | - | - | 0.480 | 0.083 | - | - |
Dividend Growth | - | - | 480.41% | - | - | - |
Gross Margin | 15.32% | 13.16% | 12.60% | 13.24% | 10.30% | 7.50% |
Operating Margin | 7.34% | 5.08% | 4.49% | 6.16% | 2.25% | -1.11% |
Profit Margin | 19.43% | 8.18% | 4.13% | 6.84% | 3.66% | -0.55% |
Free Cash Flow Margin | -24.43% | -13.56% | 12.53% | -2.56% | 5.47% | 3.87% |
EBITDA | 170.02 | 126.67 | 108.66 | 109.43 | 67.77 | 38.37 |
EBITDA Margin | 13.47% | 11.29% | 11.06% | 12.60% | 10.64% | 10.73% |
D&A For EBITDA | 77.3 | 69.64 | 64.59 | 55.91 | 53.45 | 42.35 |
EBIT | 92.72 | 57.03 | 44.07 | 53.52 | 14.32 | -3.98 |
EBIT Margin | 7.34% | 5.08% | 4.49% | 6.16% | 2.25% | -1.11% |
Effective Tax Rate | 9.52% | 16.33% | 19.66% | 25.66% | 32.65% | - |